Eye movement abnormalities in GBA1-related Parkinson’s disease and non-manifesting GBA1-carriers
Objective: To perform an in-depth characterization of eye movement abnormalities in Parkinson’s disease (PD) and non-manifesting carriers of GBA1 pathogenic variants. Background: Eye movement abnormalities…Amplification Parameters of the Alpha-Synuclein Seed Amplification Assay on CSF Predict the Clinical Subtype of Parkinson’s Disease at 10-Year Follow-Up
Objective: To assess the association between the parameters of alpha-synuclein seed amplification assay on CSF (CSF-αSyn-SAA) within 2 years from Parkinson’s disease (PD) onset and…Stratification study of alpha-synucleinopathy by body fluid biomarkers
Objective: This study aims to stratify patients with Parkinson's disease (PD) based on clinical features and several disease-associated biomarkers by analyzing the relationship between biomarkers,…Predictors of Health-Related Quality of Life in Parkinson’s Disease: A Five-Year Longitudinal Study
Objective: The aim of this study was to identify the predictors for health-related quality of life (HRQoL) in Parkinson´s disease (PD) in a 5-year longitudinal…Are Hallucinations in Parkinson’s Driven by Over-Reliance on Prior Information?
Objective: Test the validity of a theoretical model that visual hallucinations in Parkinson’s arise from over-reliance on prior information. Background: Parkinson’s hallucinations are common and…Design of the Phase 2, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of ACP-204, a Novel 5-HT2A Inverse Agonist, in Adults With Lewy Body Dementia Psychosis
Objective: To present the design for a study of ACP-204 efficacy and safety in adults with Lewy body dementia psychosis (LBDP), including Parkinson’s disease dementia…Pilot Feasibility Data using Augmented Reality and Machine Learning-Based Digital Cognitive Assessment in Parkinson’s disease
Objective: To assess the feasibility of using a novel cognitive and functional digital biomarker assessment, the Altoida NeuroMarker platform, to evaluate the presence of MCI…What women want: real-life experiences of women with Parkinson’s disease
Objective: To explore the experiences of women with Parkinson’s disease (WwPD) in healthcare access, physical and mental health, relationships, and future planning, identifying unmet needs.…Critical appraisal of MDS Criteria for diagnosing PD
Objective: To determine the validity of MDS Diagnostic criteria for PD by assessing individual diagnostic criteria in pathologically confirmed PD Background: The 2015 MDS criteria…Parkinson’s disease overlapping with other neurodegeneration-case series with neuropathological description.
Objective: The aim of the study is to report Parkinson’s disease (PD) case series with co-occurening amyotrophic lateral sclerosis (ALS) and neuropathologically characterize one case.…
- « Previous Page
- 1
- …
- 57
- 58
- 59
- 60
- 61
- …
- 436
- Next Page »